| RS148979783 |
SGCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS148979787 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ANKRD1-related dilated cardiomyopathy |
| RS1489798677 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS148980412 |
ZMYND15
|
Health Risk |
Conflicting classifications of pathogenicity |
ZMYND15-related disorder, ZMYND15-related disorder |
| RS148980576 |
CMYA5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1489806847 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS148981273 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS148981763 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS148982201 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Childhood hypophosphatasia, Infantile hypophosphatasia |
| RS1489830382 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental delay with or without epilepsy |
| RS1489831148 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS1489832770 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1489840314 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS148985177 |
SCNN1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Liddle syndrome 2, Pseudohypoaldosteronism |
| RS1489856215 |
DNAAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 18 |
| RS1489860615 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS148986773 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS148986846 |
FRRS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 37 |
| RS148986857 |
DYNC2LI1
|
Health Risk |
Likely pathogenic |
— |
| RS148987163 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Inborn genetic diseases |
| RS148987427 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
PTPN23-related disorder, PTPN23-related disorder |
| RS148987580 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS1489883516 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS148989381 |
IFNAR1
|
Health Risk |
Conflicting classifications of pathogenicity |
IFNAR1-related disorder, IFNAR1-related disorder |
| RS148989517 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS148990028 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alagille syndrome due to a JAG1 point mutation |
| RS148990124 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS148990138 |
PRKN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS148990251 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 13 |
| RS148990468 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1489915753 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1489919946 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS148992866 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148993025 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Inborn genetic diseases |
| RS148993589 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS148994527 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS148994715 |
WBP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148994877 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS148995160 |
CTPS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148995315 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis of genetic origin |
| RS148996116 |
ACSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ACSL4-related disorder |
| RS148996231 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1489967497 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1489972731 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1489983826 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS1489989834 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS148999376 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1489993778 |
ACAN
|
Health Risk |
Pathogenic/Likely pathogenic |
ACAN-related disorder, ACAN-related disorder |
| RS1489993984 |
TCIRG1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS148999583 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Inborn genetic diseases |
| RS149000433 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS149000772 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1490008675 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1490010141 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS149001183 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, TMPRSS3-related disorder |
| RS149001418 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS149001703 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS149002761 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypotonia |
| RS149002807 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS149003002 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS149003051 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS149003485 |
HSPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 13 |
| RS149003893 |
PLK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149003934 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS149004188 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMC3-related disorder |
| RS149004293 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 12, Naxos disease |
| RS149004528 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Seizures |
| RS149004972 |
BCL9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149005052 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1490051866 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS149005559 |
FRRS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 37 |
| RS149006687 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149008055 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS149008060 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 19/22, Cardiovascular phenotype |
| RS149008090 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Autoinflammatory syndrome |
| RS1490081896 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS149008479 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome |
| RS149008539 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS149009126 |
IER3IP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, epilepsy |
| RS149009269 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, 3M syndrome 2 |
| RS149009678 |
IARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1490098860 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS149010496 |
COLEC10
|
Health Risk |
Pathogenic |
3MC syndrome 3, See cases |
| RS149011081 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Generalized dominant dystrophic epidermolysis bullosa |
| RS1490116413 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1490117712 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, FAH-related disorder |
| RS1490119932 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS1490120963 |
ZNF462
|
Health Risk |
Pathogenic |
— |
| RS1490127694 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS149012859 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, Multiple myeloma |
| RS149013740 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, WFS1-related disorder |
| RS1490143139 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS149014496 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Weill-Marchesani syndrome |
| RS149016022 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, SLC4A11-related disorder |
| RS149016373 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS149017342 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 2, isolated |
| RS149017703 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS1490186766 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS149018756 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1490196552 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |